TELA Bio, Inc.
NASDAQ:TELA
2.91 (USD) • At close January 3, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 58.453 | 41.418 | 29.463 | 18.213 | 15.446 | 8.274 | 4.245 |
| Kosten van de omzet
| 18.341 | 14.374 | 10.65 | 6.979 | 6.174 | 5.332 | 1.713 |
| Brutowinst
| 40.112 | 27.044 | 18.813 | 11.234 | 9.272 | 2.942 | 2.532 |
| Brutowinstmarge
| 0.686 | 0.653 | 0.639 | 0.617 | 0.6 | 0.356 | 0.596 |
| Onderzoek- en ontwikkelingskosten
| 9.619 | 8.937 | 6.743 | 4.255 | 4.151 | 4.339 | 5.786 |
| Algemene en administratieve kosten
| 14.887 | 13.862 | 12.459 | 10.143 | 6.223 | 4.899 | 4.958 |
| Verkoop- en marketingkosten
| 59.681 | 43.252 | 29.062 | 22.111 | 18.06 | 13.646 | 8.712 |
| Verkoop-, algemene en administratieve kosten
| 74.568 | 57.114 | 41.521 | 32.254 | 24.283 | 18.545 | 13.67 |
| Overige kosten
| 0 | -0.01 | -0.228 | 0.045 | 0.351 | 0.07 | 0.094 |
| Bedrijfskosten
| 84.187 | 66.051 | 48.264 | 36.509 | 28.434 | 22.884 | 19.456 |
| Bedrijfsresultaat
| -44.075 | -39.007 | -29.451 | -25.275 | -19.162 | -17.782 | -16.924 |
| Bedrijfsresultaat ratio
| -0.754 | -0.942 | -1 | -1.388 | -1.241 | -2.149 | -3.987 |
| Totaal overige inkomsten en kosten netto
| -2.589 | -5.289 | -3.825 | -3.519 | -3.263 | -3.31 | -4.41 |
| Inkomen voor belasting
| -46.664 | -44.296 | -33.276 | -28.794 | -22.425 | -21.092 | -21.334 |
| Inkomen voor belasting ratio
| -0.798 | -1.069 | -1.129 | -1.581 | -1.452 | -2.549 | -5.026 |
| Belastingkosten
| 0 | 0.041 | 2.834 | 3.084 | 3.378 | -1.508 | 4.652 |
| Nettowinst
| -46.664 | -44.337 | -36.11 | -31.878 | -25.803 | -21.092 | -21.334 |
| Nettowinstmarge
| -0.798 | -1.07 | -1.226 | -1.75 | -1.671 | -2.549 | -5.026 |
| WPA (Winst Per Aandeel)
| -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 | -3.29 |
| Verwaterde WPA
| -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 | -3.29 |
| EBITDA
| -40.633 | -39.058 | -29.144 | -24.705 | -18.234 | -18.042 | -16.015 |
| EBITDA ratio
| -0.695 | -0.942 | -1.007 | -1.385 | -1.218 | -2.251 | -3.785 |